nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—CYP1A2—Sorafenib—thyroid cancer	0.0855	0.248	CbGbCtD
Rotigotine—CYP3A4—Vandetanib—thyroid cancer	0.0743	0.215	CbGbCtD
Rotigotine—CYP2D6—Sorafenib—thyroid cancer	0.0705	0.204	CbGbCtD
Rotigotine—CYP3A4—Sorafenib—thyroid cancer	0.0448	0.13	CbGbCtD
Rotigotine—CYP2D6—Doxorubicin—thyroid cancer	0.0427	0.124	CbGbCtD
Rotigotine—CYP3A4—Doxorubicin—thyroid cancer	0.0272	0.0788	CbGbCtD
Rotigotine—Dysaesthesia—Vandetanib—thyroid cancer	0.0271	0.0434	CcSEcCtD
Rotigotine—Balance disorder—Vandetanib—thyroid cancer	0.0214	0.0343	CcSEcCtD
Rotigotine—Haemoglobin decreased—Vandetanib—thyroid cancer	0.017	0.0273	CcSEcCtD
Rotigotine—Haemoglobin decreased—Sorafenib—thyroid cancer	0.0115	0.0184	CcSEcCtD
Rotigotine—Lethargy—Vandetanib—thyroid cancer	0.00867	0.0139	CcSEcCtD
Rotigotine—Nasopharyngitis—Vandetanib—thyroid cancer	0.0076	0.0122	CcSEcCtD
Rotigotine—Skin exfoliation—Sorafenib—thyroid cancer	0.00754	0.0121	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.00682	0.0109	CcSEcCtD
Rotigotine—Dysaesthesia—Epirubicin—thyroid cancer	0.00675	0.0108	CcSEcCtD
Rotigotine—Weight decreased—Vandetanib—thyroid cancer	0.00664	0.0107	CcSEcCtD
Rotigotine—Infestation NOS—Vandetanib—thyroid cancer	0.00655	0.0105	CcSEcCtD
Rotigotine—Infestation—Vandetanib—thyroid cancer	0.00655	0.0105	CcSEcCtD
Rotigotine—Depression—Vandetanib—thyroid cancer	0.00653	0.0105	CcSEcCtD
Rotigotine—Eczema—Sorafenib—thyroid cancer	0.00638	0.0102	CcSEcCtD
Rotigotine—Dysaesthesia—Doxorubicin—thyroid cancer	0.00624	0.01	CcSEcCtD
Rotigotine—Sinusitis—Vandetanib—thyroid cancer	0.00614	0.00985	CcSEcCtD
Rotigotine—Visual impairment—Vandetanib—thyroid cancer	0.00566	0.00908	CcSEcCtD
Rotigotine—Angiopathy—Vandetanib—thyroid cancer	0.00533	0.00855	CcSEcCtD
Rotigotine—Mediastinal disorder—Vandetanib—thyroid cancer	0.0053	0.00849	CcSEcCtD
Rotigotine—Breast disorder—Sorafenib—thyroid cancer	0.00518	0.00831	CcSEcCtD
Rotigotine—Mental disorder—Vandetanib—thyroid cancer	0.00515	0.00826	CcSEcCtD
Rotigotine—Nasopharyngitis—Sorafenib—thyroid cancer	0.00512	0.00822	CcSEcCtD
Rotigotine—Malnutrition—Vandetanib—thyroid cancer	0.00512	0.00821	CcSEcCtD
Rotigotine—Muscle spasms—Vandetanib—thyroid cancer	0.00492	0.00789	CcSEcCtD
Rotigotine—Tremor—Vandetanib—thyroid cancer	0.00479	0.00769	CcSEcCtD
Rotigotine—Erectile dysfunction—Sorafenib—thyroid cancer	0.00456	0.00732	CcSEcCtD
Rotigotine—Loss of consciousness—Vandetanib—thyroid cancer	0.0045	0.00721	CcSEcCtD
Rotigotine—Weight decreased—Sorafenib—thyroid cancer	0.00448	0.00719	CcSEcCtD
Rotigotine—Cough—Vandetanib—thyroid cancer	0.00446	0.00716	CcSEcCtD
Rotigotine—Hypertension—Vandetanib—thyroid cancer	0.00442	0.00708	CcSEcCtD
Rotigotine—Infestation NOS—Sorafenib—thyroid cancer	0.00442	0.00708	CcSEcCtD
Rotigotine—Infestation—Sorafenib—thyroid cancer	0.00442	0.00708	CcSEcCtD
Rotigotine—Arthralgia—Vandetanib—thyroid cancer	0.00435	0.00699	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00433	0.00694	CcSEcCtD
Rotigotine—Dry mouth—Vandetanib—thyroid cancer	0.00426	0.00683	CcSEcCtD
Rotigotine—Infection—Vandetanib—thyroid cancer	0.00415	0.00665	CcSEcCtD
Rotigotine—Nervous system disorder—Vandetanib—thyroid cancer	0.00409	0.00657	CcSEcCtD
Rotigotine—Skin disorder—Vandetanib—thyroid cancer	0.00406	0.0065	CcSEcCtD
Rotigotine—Connective tissue disorder—Sorafenib—thyroid cancer	0.0039	0.00625	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.0038	0.0061	CcSEcCtD
Rotigotine—Insomnia—Vandetanib—thyroid cancer	0.00378	0.00606	CcSEcCtD
Rotigotine—Paraesthesia—Vandetanib—thyroid cancer	0.00375	0.00601	CcSEcCtD
Rotigotine—Tinnitus—Sorafenib—thyroid cancer	0.0037	0.00593	CcSEcCtD
Rotigotine—Dyspepsia—Vandetanib—thyroid cancer	0.00367	0.00589	CcSEcCtD
Rotigotine—Decreased appetite—Vandetanib—thyroid cancer	0.00363	0.00582	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.0036	0.00578	CcSEcCtD
Rotigotine—Fatigue—Vandetanib—thyroid cancer	0.0036	0.00577	CcSEcCtD
Rotigotine—Angiopathy—Sorafenib—thyroid cancer	0.0036	0.00577	CcSEcCtD
Rotigotine—Immune system disorder—Sorafenib—thyroid cancer	0.00358	0.00574	CcSEcCtD
Rotigotine—Mediastinal disorder—Sorafenib—thyroid cancer	0.00357	0.00573	CcSEcCtD
Rotigotine—Constipation—Vandetanib—thyroid cancer	0.00357	0.00573	CcSEcCtD
Rotigotine—Pain—Vandetanib—thyroid cancer	0.00357	0.00573	CcSEcCtD
Rotigotine—Mental disorder—Sorafenib—thyroid cancer	0.00347	0.00557	CcSEcCtD
Rotigotine—Malnutrition—Sorafenib—thyroid cancer	0.00345	0.00553	CcSEcCtD
Rotigotine—Erythema—Sorafenib—thyroid cancer	0.00345	0.00553	CcSEcCtD
Rotigotine—Muscle spasms—Sorafenib—thyroid cancer	0.00332	0.00532	CcSEcCtD
Rotigotine—Angioedema—Sorafenib—thyroid cancer	0.00315	0.00506	CcSEcCtD
Rotigotine—Dyskinesia—Epirubicin—thyroid cancer	0.0031	0.00498	CcSEcCtD
Rotigotine—Syncope—Sorafenib—thyroid cancer	0.00309	0.00496	CcSEcCtD
Rotigotine—Loss of consciousness—Sorafenib—thyroid cancer	0.00303	0.00486	CcSEcCtD
Rotigotine—Cough—Sorafenib—thyroid cancer	0.00301	0.00483	CcSEcCtD
Rotigotine—Inflammation—Epirubicin—thyroid cancer	0.00301	0.00482	CcSEcCtD
Rotigotine—Asthenia—Vandetanib—thyroid cancer	0.003	0.0048	CcSEcCtD
Rotigotine—Hypertension—Sorafenib—thyroid cancer	0.00298	0.00478	CcSEcCtD
Rotigotine—Pruritus—Vandetanib—thyroid cancer	0.00295	0.00474	CcSEcCtD
Rotigotine—Musculoskeletal pain—Epirubicin—thyroid cancer	0.00295	0.00474	CcSEcCtD
Rotigotine—Arthralgia—Sorafenib—thyroid cancer	0.00294	0.00471	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00292	0.00468	CcSEcCtD
Rotigotine—Hiccups—Epirubicin—thyroid cancer	0.00292	0.00468	CcSEcCtD
Rotigotine—Abnormal dreams—Epirubicin—thyroid cancer	0.00288	0.00462	CcSEcCtD
Rotigotine—Dry mouth—Sorafenib—thyroid cancer	0.00287	0.00461	CcSEcCtD
Rotigotine—Dyskinesia—Doxorubicin—thyroid cancer	0.00287	0.00461	CcSEcCtD
Rotigotine—Diarrhoea—Vandetanib—thyroid cancer	0.00286	0.00458	CcSEcCtD
Rotigotine—Infection—Sorafenib—thyroid cancer	0.0028	0.00449	CcSEcCtD
Rotigotine—Skin exfoliation—Epirubicin—thyroid cancer	0.00279	0.00447	CcSEcCtD
Rotigotine—Inflammation—Doxorubicin—thyroid cancer	0.00278	0.00446	CcSEcCtD
Rotigotine—Shock—Sorafenib—thyroid cancer	0.00277	0.00444	CcSEcCtD
Rotigotine—Fluid retention—Epirubicin—thyroid cancer	0.00277	0.00444	CcSEcCtD
Rotigotine—Nervous system disorder—Sorafenib—thyroid cancer	0.00276	0.00443	CcSEcCtD
Rotigotine—Dizziness—Vandetanib—thyroid cancer	0.00276	0.00443	CcSEcCtD
Rotigotine—Skin disorder—Sorafenib—thyroid cancer	0.00274	0.00439	CcSEcCtD
Rotigotine—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.00273	0.00438	CcSEcCtD
Rotigotine—Hiccups—Doxorubicin—thyroid cancer	0.0027	0.00433	CcSEcCtD
Rotigotine—Anorexia—Sorafenib—thyroid cancer	0.00268	0.00431	CcSEcCtD
Rotigotine—Abnormal dreams—Doxorubicin—thyroid cancer	0.00267	0.00428	CcSEcCtD
Rotigotine—Vomiting—Vandetanib—thyroid cancer	0.00265	0.00426	CcSEcCtD
Rotigotine—Rash—Vandetanib—thyroid cancer	0.00263	0.00422	CcSEcCtD
Rotigotine—Dermatitis—Vandetanib—thyroid cancer	0.00263	0.00422	CcSEcCtD
Rotigotine—Headache—Vandetanib—thyroid cancer	0.00262	0.0042	CcSEcCtD
Rotigotine—Skin exfoliation—Doxorubicin—thyroid cancer	0.00258	0.00413	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00257	0.00412	CcSEcCtD
Rotigotine—Fluid retention—Doxorubicin—thyroid cancer	0.00256	0.00411	CcSEcCtD
Rotigotine—Abnormal vision—Epirubicin—thyroid cancer	0.00254	0.00408	CcSEcCtD
Rotigotine—Nausea—Vandetanib—thyroid cancer	0.00248	0.00398	CcSEcCtD
Rotigotine—Dyspepsia—Sorafenib—thyroid cancer	0.00248	0.00398	CcSEcCtD
Rotigotine—Decreased appetite—Sorafenib—thyroid cancer	0.00245	0.00393	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00243	0.0039	CcSEcCtD
Rotigotine—Fatigue—Sorafenib—thyroid cancer	0.00243	0.00389	CcSEcCtD
Rotigotine—Constipation—Sorafenib—thyroid cancer	0.00241	0.00386	CcSEcCtD
Rotigotine—Pain—Sorafenib—thyroid cancer	0.00241	0.00386	CcSEcCtD
Rotigotine—Eczema—Epirubicin—thyroid cancer	0.00236	0.00378	CcSEcCtD
Rotigotine—Abnormal vision—Doxorubicin—thyroid cancer	0.00235	0.00378	CcSEcCtD
Rotigotine—Hot flush—Epirubicin—thyroid cancer	0.00226	0.00363	CcSEcCtD
Rotigotine—Menopausal symptoms—Epirubicin—thyroid cancer	0.00224	0.0036	CcSEcCtD
Rotigotine—Urticaria—Sorafenib—thyroid cancer	0.00224	0.00359	CcSEcCtD
Rotigotine—Eczema—Doxorubicin—thyroid cancer	0.00218	0.0035	CcSEcCtD
Rotigotine—Lethargy—Epirubicin—thyroid cancer	0.00216	0.00347	CcSEcCtD
Rotigotine—Hot flush—Doxorubicin—thyroid cancer	0.00209	0.00336	CcSEcCtD
Rotigotine—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00208	0.00333	CcSEcCtD
Rotigotine—Hypersensitivity—Sorafenib—thyroid cancer	0.00207	0.00333	CcSEcCtD
Rotigotine—Asthenia—Sorafenib—thyroid cancer	0.00202	0.00324	CcSEcCtD
Rotigotine—Lethargy—Doxorubicin—thyroid cancer	0.002	0.00321	CcSEcCtD
Rotigotine—Pruritus—Sorafenib—thyroid cancer	0.00199	0.0032	CcSEcCtD
Rotigotine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00193	0.0031	CcSEcCtD
Rotigotine—Diarrhoea—Sorafenib—thyroid cancer	0.00193	0.00309	CcSEcCtD
Rotigotine—Breast disorder—Epirubicin—thyroid cancer	0.00191	0.00307	CcSEcCtD
Rotigotine—Nasopharyngitis—Epirubicin—thyroid cancer	0.00189	0.00304	CcSEcCtD
Rotigotine—Dizziness—Sorafenib—thyroid cancer	0.00186	0.00299	CcSEcCtD
Rotigotine—Vomiting—Sorafenib—thyroid cancer	0.00179	0.00287	CcSEcCtD
Rotigotine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00179	0.00287	CcSEcCtD
Rotigotine—Rash—Sorafenib—thyroid cancer	0.00178	0.00285	CcSEcCtD
Rotigotine—Dermatitis—Sorafenib—thyroid cancer	0.00177	0.00285	CcSEcCtD
Rotigotine—Breast disorder—Doxorubicin—thyroid cancer	0.00177	0.00284	CcSEcCtD
Rotigotine—Headache—Sorafenib—thyroid cancer	0.00176	0.00283	CcSEcCtD
Rotigotine—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00175	0.00281	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.0017	0.00273	CcSEcCtD
Rotigotine—Nausea—Sorafenib—thyroid cancer	0.00167	0.00268	CcSEcCtD
Rotigotine—Weight increased—Epirubicin—thyroid cancer	0.00167	0.00267	CcSEcCtD
Rotigotine—Weight decreased—Epirubicin—thyroid cancer	0.00166	0.00266	CcSEcCtD
Rotigotine—Infestation—Epirubicin—thyroid cancer	0.00163	0.00262	CcSEcCtD
Rotigotine—Infestation NOS—Epirubicin—thyroid cancer	0.00163	0.00262	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00157	0.00252	CcSEcCtD
Rotigotine—Weight increased—Doxorubicin—thyroid cancer	0.00154	0.00247	CcSEcCtD
Rotigotine—Weight decreased—Doxorubicin—thyroid cancer	0.00153	0.00246	CcSEcCtD
Rotigotine—Sinusitis—Epirubicin—thyroid cancer	0.00153	0.00246	CcSEcCtD
Rotigotine—Infestation NOS—Doxorubicin—thyroid cancer	0.00151	0.00242	CcSEcCtD
Rotigotine—Infestation—Doxorubicin—thyroid cancer	0.00151	0.00242	CcSEcCtD
Rotigotine—Oedema peripheral—Epirubicin—thyroid cancer	0.00144	0.00231	CcSEcCtD
Rotigotine—Connective tissue disorder—Epirubicin—thyroid cancer	0.00144	0.00231	CcSEcCtD
Rotigotine—Sinusitis—Doxorubicin—thyroid cancer	0.00142	0.00227	CcSEcCtD
Rotigotine—Visual impairment—Epirubicin—thyroid cancer	0.00141	0.00226	CcSEcCtD
Rotigotine—Tinnitus—Epirubicin—thyroid cancer	0.00137	0.00219	CcSEcCtD
Rotigotine—Oedema peripheral—Doxorubicin—thyroid cancer	0.00134	0.00214	CcSEcCtD
Rotigotine—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00133	0.00214	CcSEcCtD
Rotigotine—Angiopathy—Epirubicin—thyroid cancer	0.00133	0.00213	CcSEcCtD
Rotigotine—Immune system disorder—Epirubicin—thyroid cancer	0.00132	0.00212	CcSEcCtD
Rotigotine—Mediastinal disorder—Epirubicin—thyroid cancer	0.00132	0.00212	CcSEcCtD
Rotigotine—Visual impairment—Doxorubicin—thyroid cancer	0.00131	0.0021	CcSEcCtD
Rotigotine—Mental disorder—Epirubicin—thyroid cancer	0.00128	0.00206	CcSEcCtD
Rotigotine—Erythema—Epirubicin—thyroid cancer	0.00128	0.00205	CcSEcCtD
Rotigotine—Malnutrition—Epirubicin—thyroid cancer	0.00128	0.00205	CcSEcCtD
Rotigotine—Tinnitus—Doxorubicin—thyroid cancer	0.00126	0.00203	CcSEcCtD
Rotigotine—Angiopathy—Doxorubicin—thyroid cancer	0.00123	0.00197	CcSEcCtD
Rotigotine—Muscle spasms—Epirubicin—thyroid cancer	0.00123	0.00197	CcSEcCtD
Rotigotine—Immune system disorder—Doxorubicin—thyroid cancer	0.00122	0.00196	CcSEcCtD
Rotigotine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00122	0.00196	CcSEcCtD
Rotigotine—Mental disorder—Doxorubicin—thyroid cancer	0.00119	0.0019	CcSEcCtD
Rotigotine—Ill-defined disorder—Epirubicin—thyroid cancer	0.00118	0.0019	CcSEcCtD
Rotigotine—Erythema—Doxorubicin—thyroid cancer	0.00118	0.00189	CcSEcCtD
Rotigotine—Malnutrition—Doxorubicin—thyroid cancer	0.00118	0.00189	CcSEcCtD
Rotigotine—Agitation—Epirubicin—thyroid cancer	0.00117	0.00188	CcSEcCtD
Rotigotine—Malaise—Epirubicin—thyroid cancer	0.00115	0.00184	CcSEcCtD
Rotigotine—Vertigo—Epirubicin—thyroid cancer	0.00115	0.00184	CcSEcCtD
Rotigotine—Syncope—Epirubicin—thyroid cancer	0.00114	0.00183	CcSEcCtD
Rotigotine—Muscle spasms—Doxorubicin—thyroid cancer	0.00113	0.00182	CcSEcCtD
Rotigotine—Loss of consciousness—Epirubicin—thyroid cancer	0.00112	0.0018	CcSEcCtD
Rotigotine—Cough—Epirubicin—thyroid cancer	0.00111	0.00178	CcSEcCtD
Rotigotine—Hypertension—Epirubicin—thyroid cancer	0.0011	0.00177	CcSEcCtD
Rotigotine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00109	0.00176	CcSEcCtD
Rotigotine—Arthralgia—Epirubicin—thyroid cancer	0.00109	0.00174	CcSEcCtD
Rotigotine—Agitation—Doxorubicin—thyroid cancer	0.00108	0.00174	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00108	0.00173	CcSEcCtD
Rotigotine—Discomfort—Epirubicin—thyroid cancer	0.00107	0.00172	CcSEcCtD
Rotigotine—Malaise—Doxorubicin—thyroid cancer	0.00106	0.00171	CcSEcCtD
Rotigotine—Dry mouth—Epirubicin—thyroid cancer	0.00106	0.0017	CcSEcCtD
Rotigotine—Vertigo—Doxorubicin—thyroid cancer	0.00106	0.0017	CcSEcCtD
Rotigotine—Syncope—Doxorubicin—thyroid cancer	0.00106	0.0017	CcSEcCtD
Rotigotine—Confusional state—Epirubicin—thyroid cancer	0.00105	0.00168	CcSEcCtD
Rotigotine—Loss of consciousness—Doxorubicin—thyroid cancer	0.00104	0.00166	CcSEcCtD
Rotigotine—Infection—Epirubicin—thyroid cancer	0.00103	0.00166	CcSEcCtD
Rotigotine—Cough—Doxorubicin—thyroid cancer	0.00103	0.00165	CcSEcCtD
Rotigotine—Shock—Epirubicin—thyroid cancer	0.00102	0.00164	CcSEcCtD
Rotigotine—Nervous system disorder—Epirubicin—thyroid cancer	0.00102	0.00164	CcSEcCtD
Rotigotine—Hypertension—Doxorubicin—thyroid cancer	0.00102	0.00163	CcSEcCtD
Rotigotine—Skin disorder—Epirubicin—thyroid cancer	0.00101	0.00162	CcSEcCtD
Rotigotine—Hyperhidrosis—Epirubicin—thyroid cancer	0.00101	0.00161	CcSEcCtD
Rotigotine—Arthralgia—Doxorubicin—thyroid cancer	0.001	0.00161	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000998	0.0016	CcSEcCtD
Rotigotine—Discomfort—Doxorubicin—thyroid cancer	0.000993	0.00159	CcSEcCtD
Rotigotine—Anorexia—Epirubicin—thyroid cancer	0.000992	0.00159	CcSEcCtD
Rotigotine—Dry mouth—Doxorubicin—thyroid cancer	0.000982	0.00158	CcSEcCtD
Rotigotine—Hypotension—Epirubicin—thyroid cancer	0.000973	0.00156	CcSEcCtD
Rotigotine—Confusional state—Doxorubicin—thyroid cancer	0.000971	0.00156	CcSEcCtD
Rotigotine—Infection—Doxorubicin—thyroid cancer	0.000957	0.00153	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000948	0.00152	CcSEcCtD
Rotigotine—Shock—Doxorubicin—thyroid cancer	0.000947	0.00152	CcSEcCtD
Rotigotine—Nervous system disorder—Doxorubicin—thyroid cancer	0.000944	0.00151	CcSEcCtD
Rotigotine—Insomnia—Epirubicin—thyroid cancer	0.000941	0.00151	CcSEcCtD
Rotigotine—Skin disorder—Doxorubicin—thyroid cancer	0.000935	0.0015	CcSEcCtD
Rotigotine—Paraesthesia—Epirubicin—thyroid cancer	0.000935	0.0015	CcSEcCtD
Rotigotine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000931	0.00149	CcSEcCtD
Rotigotine—Somnolence—Epirubicin—thyroid cancer	0.000925	0.00148	CcSEcCtD
Rotigotine—Anorexia—Doxorubicin—thyroid cancer	0.000918	0.00147	CcSEcCtD
Rotigotine—Dyspepsia—Epirubicin—thyroid cancer	0.000916	0.00147	CcSEcCtD
Rotigotine—Decreased appetite—Epirubicin—thyroid cancer	0.000905	0.00145	CcSEcCtD
Rotigotine—Hypotension—Doxorubicin—thyroid cancer	0.0009	0.00144	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000899	0.00144	CcSEcCtD
Rotigotine—Fatigue—Epirubicin—thyroid cancer	0.000897	0.00144	CcSEcCtD
Rotigotine—Constipation—Epirubicin—thyroid cancer	0.00089	0.00143	CcSEcCtD
Rotigotine—Pain—Epirubicin—thyroid cancer	0.00089	0.00143	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000877	0.00141	CcSEcCtD
Rotigotine—Insomnia—Doxorubicin—thyroid cancer	0.000871	0.0014	CcSEcCtD
Rotigotine—Paraesthesia—Doxorubicin—thyroid cancer	0.000865	0.00139	CcSEcCtD
Rotigotine—Feeling abnormal—Epirubicin—thyroid cancer	0.000858	0.00138	CcSEcCtD
Rotigotine—Somnolence—Doxorubicin—thyroid cancer	0.000856	0.00137	CcSEcCtD
Rotigotine—Dyspepsia—Doxorubicin—thyroid cancer	0.000848	0.00136	CcSEcCtD
Rotigotine—Decreased appetite—Doxorubicin—thyroid cancer	0.000837	0.00134	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000831	0.00133	CcSEcCtD
Rotigotine—Fatigue—Doxorubicin—thyroid cancer	0.00083	0.00133	CcSEcCtD
Rotigotine—Urticaria—Epirubicin—thyroid cancer	0.000827	0.00133	CcSEcCtD
Rotigotine—Constipation—Doxorubicin—thyroid cancer	0.000824	0.00132	CcSEcCtD
Rotigotine—Pain—Doxorubicin—thyroid cancer	0.000824	0.00132	CcSEcCtD
Rotigotine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000794	0.00127	CcSEcCtD
Rotigotine—Hypersensitivity—Epirubicin—thyroid cancer	0.000767	0.00123	CcSEcCtD
Rotigotine—Urticaria—Doxorubicin—thyroid cancer	0.000765	0.00123	CcSEcCtD
Rotigotine—Asthenia—Epirubicin—thyroid cancer	0.000747	0.0012	CcSEcCtD
Rotigotine—Pruritus—Epirubicin—thyroid cancer	0.000736	0.00118	CcSEcCtD
Rotigotine—Diarrhoea—Epirubicin—thyroid cancer	0.000712	0.00114	CcSEcCtD
Rotigotine—Hypersensitivity—Doxorubicin—thyroid cancer	0.00071	0.00114	CcSEcCtD
Rotigotine—Asthenia—Doxorubicin—thyroid cancer	0.000691	0.00111	CcSEcCtD
Rotigotine—Dizziness—Epirubicin—thyroid cancer	0.000688	0.0011	CcSEcCtD
Rotigotine—Pruritus—Doxorubicin—thyroid cancer	0.000681	0.00109	CcSEcCtD
Rotigotine—Vomiting—Epirubicin—thyroid cancer	0.000662	0.00106	CcSEcCtD
Rotigotine—Diarrhoea—Doxorubicin—thyroid cancer	0.000659	0.00106	CcSEcCtD
Rotigotine—Rash—Epirubicin—thyroid cancer	0.000656	0.00105	CcSEcCtD
Rotigotine—Dermatitis—Epirubicin—thyroid cancer	0.000656	0.00105	CcSEcCtD
Rotigotine—Headache—Epirubicin—thyroid cancer	0.000652	0.00105	CcSEcCtD
Rotigotine—Dizziness—Doxorubicin—thyroid cancer	0.000637	0.00102	CcSEcCtD
Rotigotine—Nausea—Epirubicin—thyroid cancer	0.000618	0.000992	CcSEcCtD
Rotigotine—Vomiting—Doxorubicin—thyroid cancer	0.000612	0.000982	CcSEcCtD
Rotigotine—Rash—Doxorubicin—thyroid cancer	0.000607	0.000974	CcSEcCtD
Rotigotine—Dermatitis—Doxorubicin—thyroid cancer	0.000607	0.000973	CcSEcCtD
Rotigotine—Headache—Doxorubicin—thyroid cancer	0.000603	0.000968	CcSEcCtD
Rotigotine—Nausea—Doxorubicin—thyroid cancer	0.000572	0.000918	CcSEcCtD
Rotigotine—DRD3—GPCR downstream signaling—SST—thyroid cancer	5.71e-05	0.00181	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—MINPP1—thyroid cancer	5.68e-05	0.0018	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—PTCH1—thyroid cancer	5.67e-05	0.0018	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—MEN1—thyroid cancer	5.65e-05	0.00179	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—CALCA—thyroid cancer	5.62e-05	0.00178	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—TSHR—thyroid cancer	5.62e-05	0.00178	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—CALCA—thyroid cancer	5.57e-05	0.00177	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—CALCA—thyroid cancer	5.5e-05	0.00174	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TCF7L1—thyroid cancer	5.46e-05	0.00173	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TCF7L1—thyroid cancer	5.38e-05	0.00171	CbGpPWpGaD
Rotigotine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	5.32e-05	0.00169	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—SST—thyroid cancer	5.26e-05	0.00167	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—SST—thyroid cancer	5.19e-05	0.00164	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—SST—thyroid cancer	5.16e-05	0.00164	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—PTCH1—thyroid cancer	5.12e-05	0.00162	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—PTCH1—thyroid cancer	5.11e-05	0.00162	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—TSHR—thyroid cancer	5.11e-05	0.00162	CbGpPWpGaD
Rotigotine—DRD4—Circadian rythm related genes—TP53—thyroid cancer	5.09e-05	0.00161	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—CDK1—thyroid cancer	5.09e-05	0.00161	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—PTEN—thyroid cancer	5.07e-05	0.00161	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—CALCA—thyroid cancer	5.06e-05	0.0016	CbGpPWpGaD
Rotigotine—CYP3A4—Biological oxidations—RXRA—thyroid cancer	5.06e-05	0.0016	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—PRKAR1A—thyroid cancer	5.02e-05	0.00159	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—CALCA—thyroid cancer	4.99e-05	0.00158	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—SST—thyroid cancer	4.98e-05	0.00158	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—CALCA—thyroid cancer	4.97e-05	0.00157	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—PTCH1—thyroid cancer	4.94e-05	0.00157	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TCF7L1—thyroid cancer	4.86e-05	0.00154	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—NDUFA13—thyroid cancer	4.83e-05	0.00153	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—MINPP1—thyroid cancer	4.82e-05	0.00153	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—CALCA—thyroid cancer	4.79e-05	0.00152	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TCF7L1—thyroid cancer	4.69e-05	0.00149	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—SST—thyroid cancer	4.68e-05	0.00149	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—SST—thyroid cancer	4.68e-05	0.00148	CbGpPWpGaD
Rotigotine—DRD1—Circadian rythm related genes—TP53—thyroid cancer	4.59e-05	0.00145	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—CDK1—thyroid cancer	4.58e-05	0.00145	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CHST14—thyroid cancer	4.54e-05	0.00144	CbGpPWpGaD
Rotigotine—DRD3—Circadian rythm related genes—TP53—thyroid cancer	4.52e-05	0.00143	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—SST—thyroid cancer	4.52e-05	0.00143	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—CDK1—thyroid cancer	4.52e-05	0.00143	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—CALCA—thyroid cancer	4.51e-05	0.00143	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—CALCA—thyroid cancer	4.5e-05	0.00143	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TSHR—thyroid cancer	4.44e-05	0.00141	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—SST—thyroid cancer	4.37e-05	0.00139	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PRKAR1A—thyroid cancer	4.37e-05	0.00138	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—CALCA—thyroid cancer	4.35e-05	0.00138	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—PTCH1—thyroid cancer	4.34e-05	0.00138	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—CALCA—thyroid cancer	4.21e-05	0.00133	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MEN1—thyroid cancer	4.17e-05	0.00132	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TCF7L1—thyroid cancer	4.12e-05	0.00131	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—NDUFA13—thyroid cancer	4.09e-05	0.0013	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—CDK1—thyroid cancer	4.08e-05	0.00129	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—CDK1—thyroid cancer	4.07e-05	0.00129	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TSHR—thyroid cancer	3.99e-05	0.00127	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—SST—thyroid cancer	3.97e-05	0.00126	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TSHR—thyroid cancer	3.94e-05	0.00125	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—CDK1—thyroid cancer	3.94e-05	0.00125	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PRKAR1A—thyroid cancer	3.93e-05	0.00125	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PRKAR1A—thyroid cancer	3.88e-05	0.00123	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CHST14—thyroid cancer	3.85e-05	0.00122	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—CALCA—thyroid cancer	3.82e-05	0.00121	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PTCH1—thyroid cancer	3.77e-05	0.0012	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MEN1—thyroid cancer	3.76e-05	0.00119	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—MINPP1—thyroid cancer	3.72e-05	0.00118	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MEN1—thyroid cancer	3.71e-05	0.00117	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—HPGD—thyroid cancer	3.66e-05	0.00116	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TSHR—thyroid cancer	3.56e-05	0.00113	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PRKAR1A—thyroid cancer	3.5e-05	0.00111	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—TP53—thyroid cancer	3.46e-05	0.0011	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—CDK1—thyroid cancer	3.46e-05	0.0011	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—SST—thyroid cancer	3.45e-05	0.00109	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TSHR—thyroid cancer	3.44e-05	0.00109	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PTCH1—thyroid cancer	3.4e-05	0.00108	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PRKAR1A—thyroid cancer	3.38e-05	0.00107	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PTCH1—thyroid cancer	3.35e-05	0.00106	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MEN1—thyroid cancer	3.35e-05	0.00106	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CALCA—thyroid cancer	3.32e-05	0.00105	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—NRG1—thyroid cancer	3.27e-05	0.00104	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MEN1—thyroid cancer	3.23e-05	0.00102	CbGpPWpGaD
Rotigotine—ADRA2B—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	3.2e-05	0.00101	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	3.16e-05	0.001	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—SST—thyroid cancer	3.11e-05	0.000985	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—HPGD—thyroid cancer	3.1e-05	0.000984	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—SST—thyroid cancer	3.07e-05	0.000972	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PTCH1—thyroid cancer	3.03e-05	0.000959	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TSHR—thyroid cancer	3.02e-05	0.000956	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CDK1—thyroid cancer	3.01e-05	0.000953	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CALCA—thyroid cancer	2.99e-05	0.000948	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CHST14—thyroid cancer	2.97e-05	0.000942	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PRKAR1A—thyroid cancer	2.97e-05	0.000941	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CALCA—thyroid cancer	2.95e-05	0.000935	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TERT—thyroid cancer	2.94e-05	0.000931	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PTCH1—thyroid cancer	2.92e-05	0.000926	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MEN1—thyroid cancer	2.84e-05	0.000899	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—HIF1A—thyroid cancer	2.81e-05	0.00089	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—SST—thyroid cancer	2.77e-05	0.000877	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CDK1—thyroid cancer	2.71e-05	0.000858	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—SST—thyroid cancer	2.67e-05	0.000847	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CDK1—thyroid cancer	2.67e-05	0.000847	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CALCA—thyroid cancer	2.66e-05	0.000844	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CALCA—thyroid cancer	2.57e-05	0.000815	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PTCH1—thyroid cancer	2.56e-05	0.000813	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—NRAS—thyroid cancer	2.55e-05	0.000809	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.52e-05	0.000798	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—NRAS—thyroid cancer	2.47e-05	0.000784	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NRG1—thyroid cancer	2.41e-05	0.000765	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CDK1—thyroid cancer	2.41e-05	0.000764	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—HPGD—thyroid cancer	2.4e-05	0.000759	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—SST—thyroid cancer	2.35e-05	0.000744	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CDK1—thyroid cancer	2.33e-05	0.000738	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—BRAF—thyroid cancer	2.33e-05	0.000737	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CALCA—thyroid cancer	2.26e-05	0.000716	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—KRAS—thyroid cancer	2.2e-05	0.000696	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NRG1—thyroid cancer	2.17e-05	0.000689	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TERT—thyroid cancer	2.17e-05	0.000687	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NRG1—thyroid cancer	2.14e-05	0.00068	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—KRAS—thyroid cancer	2.13e-05	0.000675	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—TPR—thyroid cancer	2.1e-05	0.000667	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—HIF1A—thyroid cancer	2.07e-05	0.000657	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	2.07e-05	0.000656	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CDK1—thyroid cancer	2.04e-05	0.000648	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—TP53—thyroid cancer	1.95e-05	0.000619	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TERT—thyroid cancer	1.95e-05	0.000618	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NRG1—thyroid cancer	1.94e-05	0.000614	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TERT—thyroid cancer	1.92e-05	0.00061	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NRG1—thyroid cancer	1.87e-05	0.000592	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—HRAS—thyroid cancer	1.87e-05	0.000592	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—HIF1A—thyroid cancer	1.87e-05	0.000591	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—HIF1A—thyroid cancer	1.84e-05	0.000584	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—NRAS—thyroid cancer	1.83e-05	0.000579	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—HRAS—thyroid cancer	1.81e-05	0.000574	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—TPR—thyroid cancer	1.78e-05	0.000565	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—AKT1—thyroid cancer	1.76e-05	0.000558	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.75e-05	0.000556	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TERT—thyroid cancer	1.74e-05	0.000551	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—BRAF—thyroid cancer	1.72e-05	0.000544	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—CCND1—thyroid cancer	1.7e-05	0.000538	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TERT—thyroid cancer	1.68e-05	0.000532	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—HIF1A—thyroid cancer	1.66e-05	0.000527	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—AKT1—thyroid cancer	1.65e-05	0.000522	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—NRAS—thyroid cancer	1.64e-05	0.000521	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NRG1—thyroid cancer	1.64e-05	0.00052	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—PTEN—thyroid cancer	1.64e-05	0.000519	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—NRAS—thyroid cancer	1.62e-05	0.000514	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HIF1A—thyroid cancer	1.6e-05	0.000509	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—AKT1—thyroid cancer	1.6e-05	0.000507	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.59e-05	0.000504	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.57e-05	0.000499	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—KRAS—thyroid cancer	1.57e-05	0.000498	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—BRAF—thyroid cancer	1.54e-05	0.00049	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—BRAF—thyroid cancer	1.52e-05	0.000483	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TERT—thyroid cancer	1.47e-05	0.000467	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—NRAS—thyroid cancer	1.46e-05	0.000464	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—NRAS—thyroid cancer	1.46e-05	0.000463	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—KRAS—thyroid cancer	1.41e-05	0.000448	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—NRAS—thyroid cancer	1.41e-05	0.000448	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HIF1A—thyroid cancer	1.41e-05	0.000447	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—KRAS—thyroid cancer	1.4e-05	0.000442	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—BRAF—thyroid cancer	1.38e-05	0.000436	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—TPR—thyroid cancer	1.38e-05	0.000436	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.35e-05	0.000429	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—HRAS—thyroid cancer	1.34e-05	0.000423	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.33e-05	0.000423	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—BRAF—thyroid cancer	1.33e-05	0.000421	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—RXRA—thyroid cancer	1.32e-05	0.00042	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—AKT1—thyroid cancer	1.3e-05	0.000412	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—KRAS—thyroid cancer	1.26e-05	0.000399	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—KRAS—thyroid cancer	1.26e-05	0.000399	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CCND1—thyroid cancer	1.25e-05	0.000397	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.25e-05	0.000396	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—NRAS—thyroid cancer	1.24e-05	0.000393	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—KRAS—thyroid cancer	1.22e-05	0.000386	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PTEN—thyroid cancer	1.21e-05	0.000383	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—HRAS—thyroid cancer	1.2e-05	0.000381	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—HRAS—thyroid cancer	1.19e-05	0.000376	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—AKT1—thyroid cancer	1.18e-05	0.000374	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—AKT1—thyroid cancer	1.17e-05	0.000371	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—BRAF—thyroid cancer	1.17e-05	0.00037	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—AKT1—thyroid cancer	1.15e-05	0.000366	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CCND1—thyroid cancer	1.13e-05	0.000357	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—RXRA—thyroid cancer	1.12e-05	0.000355	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TP53—thyroid cancer	1.12e-05	0.000354	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CCND1—thyroid cancer	1.11e-05	0.000353	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.09e-05	0.000346	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PTEN—thyroid cancer	1.09e-05	0.000345	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NRAS—thyroid cancer	1.08e-05	0.000342	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PTEN—thyroid cancer	1.07e-05	0.00034	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—HRAS—thyroid cancer	1.07e-05	0.00034	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—HRAS—thyroid cancer	1.07e-05	0.000339	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—KRAS—thyroid cancer	1.07e-05	0.000339	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—AKT1—thyroid cancer	1.06e-05	0.000337	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—AKT1—thyroid cancer	1.05e-05	0.000332	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—AKT1—thyroid cancer	1.04e-05	0.00033	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	1.03e-05	0.000328	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.03e-05	0.000326	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	1.01e-05	0.000319	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CCND1—thyroid cancer	1e-05	0.000318	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NRAS—thyroid cancer	9.71e-06	0.000308	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CCND1—thyroid cancer	9.7e-06	0.000307	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PTEN—thyroid cancer	9.69e-06	0.000307	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NRAS—thyroid cancer	9.58e-06	0.000304	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—AKT1—thyroid cancer	9.46e-06	0.0003	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—AKT1—thyroid cancer	9.44e-06	0.000299	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PTEN—thyroid cancer	9.36e-06	0.000297	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—KRAS—thyroid cancer	9.28e-06	0.000294	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	9.13e-06	0.000289	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—HRAS—thyroid cancer	9.08e-06	0.000288	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	8.83e-06	0.00028	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—RXRA—thyroid cancer	8.65e-06	0.000274	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NRAS—thyroid cancer	8.65e-06	0.000274	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCND1—thyroid cancer	8.51e-06	0.00027	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—KRAS—thyroid cancer	8.36e-06	0.000265	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PPARG—thyroid cancer	8.36e-06	0.000265	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NRAS—thyroid cancer	8.35e-06	0.000265	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TP53—thyroid cancer	8.25e-06	0.000262	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—KRAS—thyroid cancer	8.25e-06	0.000261	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PTEN—thyroid cancer	8.22e-06	0.00026	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—AKT1—thyroid cancer	8.02e-06	0.000254	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—HRAS—thyroid cancer	7.89e-06	0.00025	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—KRAS—thyroid cancer	7.44e-06	0.000236	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TP53—thyroid cancer	7.43e-06	0.000235	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NRAS—thyroid cancer	7.33e-06	0.000232	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TP53—thyroid cancer	7.33e-06	0.000232	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—KRAS—thyroid cancer	7.19e-06	0.000228	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—HRAS—thyroid cancer	7.1e-06	0.000225	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PPARG—thyroid cancer	7.08e-06	0.000224	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—HRAS—thyroid cancer	7.01e-06	0.000222	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—AKT1—thyroid cancer	6.97e-06	0.000221	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TP53—thyroid cancer	6.62e-06	0.00021	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTGS2—thyroid cancer	6.57e-06	0.000208	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TP53—thyroid cancer	6.39e-06	0.000202	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—HRAS—thyroid cancer	6.33e-06	0.000201	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—KRAS—thyroid cancer	6.31e-06	0.0002	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—AKT1—thyroid cancer	6.27e-06	0.000199	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—AKT1—thyroid cancer	6.19e-06	0.000196	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HRAS—thyroid cancer	6.11e-06	0.000194	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTEN—thyroid cancer	5.73e-06	0.000182	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TP53—thyroid cancer	5.61e-06	0.000178	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—AKT1—thyroid cancer	5.59e-06	0.000177	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTGS2—thyroid cancer	5.57e-06	0.000177	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PPARG—thyroid cancer	5.46e-06	0.000173	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—AKT1—thyroid cancer	5.39e-06	0.000171	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HRAS—thyroid cancer	5.36e-06	0.00017	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTEN—thyroid cancer	4.86e-06	0.000154	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—AKT1—thyroid cancer	4.74e-06	0.00015	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTGS2—thyroid cancer	4.3e-06	0.000136	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTEN—thyroid cancer	3.75e-06	0.000119	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—AKT1—thyroid cancer	3.3e-06	0.000105	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—AKT1—thyroid cancer	2.8e-06	8.87e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—AKT1—thyroid cancer	2.16e-06	6.85e-05	CbGpPWpGaD
